RICCHINI, FRANCESCA
RICCHINI, FRANCESCA
Universita' degli Studi di MILANO
Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial
2019 F. Ricchini, A. Caraceni, E. Zecca, A. Pigni, F. Centurioni, A. Manzoni, S. Kaasa, C. Brunelli
Best practices for the management of local-regional recurrent chordoma : a position paper by the Chordoma Global Consensus Group
2017 S. Stacchiotti, A. Gronchi, P. Fossati, T. Akiyama, C. Alapetite, M. Baumann, J.Y. Blay, S. Bolle, S. Boriani, P. Bruzzi, R. Capanna, A. Caraceni, R. Casadei, V. Colia, J. Debus, T. Delaney, A. Desai, P. Dileo, S. Dijkstra, F. Doglietto, A. Flanagan, S. Froelich, P.A. Gardner, H. Gelderblom, Z.L. Gokaslan, R. Haas, C. Heery, N. Hindi, P. Hohenberger, F. Hornicek, R. Imai, L. Jeys, R.L. Jones, B. Kasper, A. Kawai, M. Krengli, A. Leithner, I. Logowska, J. Martin Broto, D. Mazzatenta, C. Morosi, P. Nicolai, O.J. Norum, S. Patel, N. Penel, P. Picci, S. Pilotti, S. Radaelli, F. Ricchini, P. Rutkowski, S. Scheipl, C. Sen, E. Tamborini, K.A. Thornton, B. Timmermann, V. Torri, P.U. Tunn, M. Uhl, Y. Yamada, D.C. Weber, D. Vanel, P.P. Varga, C.L.A. Vleggeert-Lankamp, P.G. Casali, J. Sommer
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer
2015 M. Di Bartolomeo, C. Maggi, F. Ricchini, F. Pietrantonio, R. Iacovelli, F. de Braud, A. Inno
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase
2015 F.S. Falvella, M. Caporale, S. Cheli, A. Martinetti, R. Berenato, C. Maggi, M. Niger, F. Ricchini, I. Bossi, M. Di Bartolomeo, E. Sottotetti, F.F. Bernardi, F. de Braud, E. Clementi, F. Pietrantonio
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma
2014 F. Pietrantonio, C. Maggi, G. Fanetti, R. Iacovelli, M. Di Bartolomeo, F. Ricchini, M. Deraco, F. Perrone, D. Baratti, S. Kusamura, E. Tamborini, A. Castano, P.V. Consonni, I. Bossi, C. Gavazzi, M. Milione, G. Pelosi, F. de Braud
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies
2014 R. Iacovelli, F. Pietrantonio, A. Farcomeni, C. Maggi, A. Palazzo, F. Ricchini, F. De Braud, M. Di Bartolomeo
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil : a meta-analysis of published trials
2014 R. Iacovelli, F. Pietrantonio, A. Palazzo, C. Maggi, F. Ricchini, F. De Braud, M. Di Bartolomeo
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? : Analysis of a phase II trial
2013 S. Damian, L. Celio, E. De Benedictis, P. Mariani, F. Agustoni, F. Ricchini, F. De Braud
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting
2013 L. Celio, F. Ricchini, F. De Braud